-
EMA to monitor real world use of COVID-19 treatments and vaccines
europeanpharmaceuticalreview
July 24, 2020
The EMA has built up an infrastructure to allow for the monitoring of COVID-19 treatments and vaccines used in clinical practice.
-
China’s Sinopharm says coronavirus vaccine could be ready by year-end – state media
expresspharma
July 24, 2020
Sinopharm Chairman Liu Jingzhen told state broadcaster CCTV the company expects to finish late-stage human testing within about three months.
-
Promise and prevention: Experts discuss the race for a COVID-19 vaccine
expresspharma
July 24, 2020
As the global race for a COVID-19 vaccine heats up, Reuters invited a group of healthcare experts to answer questions as part of our #AskReuters Twitter chat series.
-
Wave of promising study results raises hopes for coronavirus vaccines
expresspharma
July 22, 2020
Whether any of these efforts will result in a vaccine capable of protecting billions of people and ending the global pandemic that has claimed more than 600,000 lives is still far from clear.
-
Valneva to Provide SARS-CoV-2 Vax Candidate to UK Govt
contractpharma
July 21, 2020
Valneva's VLA2001, an inactivated whole virus vaccine candidate against coronavirus is expected to enter clinical studies by the end of 2020.
-
Seven Indian pharmaceutical companies race to develop vaccine for deadly coronavirus
expresspharma
July 20, 2020
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
-
US fast tracks Pfizer/BioNTech coronavirus vaccines
pharmatimes
July 17, 2020
US regulators have fast-tracked Pfizer and BioNTech's novel coronavirus vaccine candidates BNT162b1 and BNT162b2.
-
Greater global cooperation needed to tackle vaccine-preventable diseases in a world with COVID-19
expresspharma
July 17, 2020
The authors of the study also included researchers at the University of Ghana, Imperial College London, the Center for Global Development Europe, London School of Hygiene & Tropical Medicine and the University of Cambridge.
-
Swiftly waning COVID-19 immunity poses vaccination challenge
expresspharma
July 16, 2020
Preliminary studies in China, Germany, Britain and elsewhere have found that patients infected with the novel coronavirus make protective antibodies as part of their immune system’s defences, but these appear to last only a few months.
-
Moderna Phase 1 results show coronavirus vaccine safe, induces immune response
expresspharma
July 16, 2020
Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19: Moderna's research team.